Oxidative stress resistance and fitness-compensatory response in vancomycin-intermediate Staphylococcus aureus (VISA)

被引：2
|
作者：
Tan, Xin-Ee [1 ,3 ]
Neoh, Hui-min [1 ,2 ]
Cui, Longzhu [3 ]
Hiramatsu, Keiichi [2 ]
Jamal, Rahman [1 ]
机构：
[1] Univ Kebangsaan Malaysia, UKM Med Mol Biol Inst UMBI, Bangi, Malaysia
[2] Juntendo Univ, Sch Med, Dept Bacteriol, Tokyo, Japan
[3] Jichi Med Univ, Sch Med, Dept Infect & Immun, Div Bacteriol, Shimotsuke, Tochigi, Japan
来源：
CANADIAN JOURNAL OF MICROBIOLOGY | 2019年 / 65卷 / 08期
关键词：
vancomycin-intermediate Staphylococcus aureus; oxidative stress; virulence; fitness cost; METHIONINE SULFOXIDE REDUCTASES; VIRULENCE; MODEL;
D O I：
10.1139/cjm-2019-0048
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
In this study, vancomycin-intermediate Staphylococcus aureus (VISA) cells carrying vraS and (or) graR mutations were shown to be more resistant to oxidative stress. Caenorhabditis elegans infected with these strains in turn demonstrated lower survival. Altered regulation in oxidative stress response and virulence appear to be physiological adaptations associated with the VISA phenotype in the Mu50 lineage.
引用
收藏
页码：623 / 628
页数：6
相关论文
共 50 条
  • [41] Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA
    Lai, Chih-Cheng
    Chen, Chi-Chung
    Chuang, Yin-Ching
    Tang, Hung-Jen
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S138 - S138
  • [42] Impact of Inoculum Size and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) on Vancomycin Activity and Emergence of VISA in an In Vitro Pharmacodynamic Model
    Rose, Warren E.
    Leonard, Steven N.
    Rossi, Kerri L.
    Kaatz, Glenn W.
    Rybak, Michael J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) : 805 - 807
  • [43] Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA
    Chih-Cheng Lai
    Chi-Chung Chen
    Yin-Ching Chuang
    Hung-Jen Tang
    Scientific Reports, 7
  • [44] Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model
    Zhanel, George G.
    Voth, Dylan
    Nichol, Kim
    Karlowsky, James A.
    Noreddin, Ayman M.
    Hoban, Daryl J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (02) : 364 - 369
  • [45] A Mutation of RNA Polymerase β′ Subunit (RpoC) Converts Heterogeneously Vancomycin-Intermediate Staphylococcus aureus (hVISA) into "Slow VISA"
    Matsuo, Miki
    Hishinuma, Tomomi
    Katayama, Yuki
    Hiramatsu, Keiichi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (07) : 4215 - 4225
  • [46] Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant Staphylococcus aureus
    Capin, Busra Betul Ozmen
    Tekeli, Alper
    Karahan, Zeynep Ceren
    MICROBIAL DRUG RESISTANCE, 2020, 26 (03) : 238 - 244
  • [47] Contribution of Selected Gene Mutations to Resistance in Clinical Isolates of Vancomycin-Intermediate Staphylococcus aureus
    Hafer, Cory
    Lin, Ying
    Kornblum, John
    Lowy, Franklin D.
    Uhlemann, Anne-Catrin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5845 - 5851
  • [48] Dissecting Vancomycin-Intermediate Resistance in Staphylococcus aureus Using Genome-Wide Association
    Alam, Md Tauqeer
    Petit, Robert A., III
    Crispell, Emily K.
    Thornton, Timothy A.
    Conneely, Karen N.
    Jiang, Yunxuan
    Satola, Sarah W.
    Read, Timothy D.
    GENOME BIOLOGY AND EVOLUTION, 2014, 6 (05): : 1174 - 1185
  • [49] Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates
    Zhang, Shanshan
    Sun, Xiaoxi
    Chang, Wenjiao
    Dai, Yuanyuan
    Ma, Xiaoling
    PLOS ONE, 2015, 10 (08):
  • [50] Emergence of vancomycin-intermediate resistant Staphylococcus aureus in north of Palestine
    Adwan, Ghaleb
    Abu-Shanab, Bassam
    Odeh, Marwan
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2009, 2 (05) : 44 - 48
12345